Insys Therapeutics beats by $0.05, misses on revenue

• Insys Therapeutics (INSY): Q3 EPS of $0.07 beats by $0.05.
• Revenue of $55.18M (-39.5% Y/Y) misses by $0.79M.
• Press Release